P. Kuchulakanti

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, American Journal of Cardiology.

Three‐year follow‐up after intravascular γ‐radiation for in‐stent restenosis in saphenous vein grafts

P. Teirstein, K. Kent, A. Pichard, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents

K. Kent, A. Pichard, L. Satler, 2006, Circulation.

Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.

N. Weissman, K. Kent, A. Pichard, 2006, The Journal of invasive cardiology.

Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.

P. Jariwala, P. Kuchulakanti, Narasaraju Kavalipati, 2020, Indian heart journal.

Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients.

T. L. Pinto, K. Kent, A. Pichard, 2006, The American journal of cardiology.

Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries

Karl-Heinz Waldmann, Axel Haverich, Claus Harder, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Peroxisome proliferator-activated receptor γ: Its role in metabolic syndrome

R. Pakala, R. Waksman, S. Rha, 2004 .

Peroxisome proliferator-activated receptor γ

R. Pakala, R. Waksman, S. Rha, 2004 .

Intracoronary fracture and embolization of a coronary angioplasty balloon catheter: Retrieval by a simple technique

P. Kuchulakanti, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent.

K. Kent, A. Pichard, L. Satler, 2004, The American journal of cardiology.

Therapeutic Potential of Oral Antiproliferative Agents in the Prevention of Coronary Restenosis

R. Waksman, P. Kuchulakanti, R. Waksman, 2012, Drugs.

Brachytherapy and bivalirudin evaluation study.

K. Kent, A. Pichard, L. Satler, 2005, American heart journal.

Sirolimus‐eluting stents and calcified coronary lesions: Clinical outcomes of patients treated with and without rotational atherectomy

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of three or more sirolimus‐eluting stents versus paclitaxel‐eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention

K. Kent, A. Pichard, L. Satler, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.

K. Kent, A. Pichard, L. Satler, 2005, The American journal of cardiology.

Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Optimizing dosimetry with high-dose intracoronary gamma radiation (21 Gy) for patients with diffuse in-stent restenosis.

K. Kent, A. Pichard, L. Satler, 2004, Cardiovascular revascularization medicine : including molecular interventions.

Efficacy of sirolimus-eluting stents as compared to paclitaxel-eluting stents for saphenous vein graft intervention.

K. Kent, A. Pichard, L. Satler, 2006, Journal of interventional cardiology.

Sirolimus- versus paclitaxel-eluting stents: numero uno, first among equals or equal?

R. Waksman, P. Kuchulakanti, 2006, Future cardiology.

Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis.

N. Weissman, G. Mintz, K. Kent, 2006, The American journal of cardiology.

Safety of percutaneous coronary intervention alone in symptomatic patients with moderate and severe valvular aortic stenosis and coexisting coronary artery disease: analysis of results in 56 patients.

N. Weissman, K. Kent, A. Pichard, 2004, The Journal of invasive cardiology.

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.

N. Weissman, K. Kent, A. Pichard, 2004, Journal of the American College of Cardiology.

Bivalirudin compared with IIb/IIIa inhibitors in patients with in-stent restenosis undergoing intracoronary brachytherapy.

K. Kent, A. Pichard, L. Satler, 2005, Cardiovascular revascularization medicine : including molecular interventions.

Recurrent Pulmonary Arteriovenous Malformation with Embolization

vcs, P. Kuchulakanti, Srinivasarao Bandaru, 2019 .

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.

T. L. Pinto, K. Kent, A. Pichard, 2006, Cardiovascular revascularization medicine : including molecular interventions.

Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention.

K. Kent, A. Pichard, L. Satler, 2006, The American journal of cardiology.

Selective versus exclusive use of sirolimus‐eluting stent implantation in multivessel coronary artery disease

K. Kent, A. Pichard, L. Satler, 2005, Catheterization and cardiovascular interventions.

Impact of sirolimus‐eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty

K. Kent, A. Pichard, L. Satler, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Chapter 17 – Intracoronary brachytherapy

R. Waksman, P. Kuchulakanti, R. Waksman, 2008 .

Mechanisms and methods to resolve edge effect.

R. Waksman, R. Lew, P. Kuchulakanti, 2003, The Journal of invasive cardiology.

Real‐world clinical practice of intracoronary radiation therapy as compared to investigational trials

K. Kent, A. Pichard, L. Satler, 2005 .

Percutaneous coronary intervention with drug‐eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes

N. Weissman, K. Kent, A. Pichard, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Bivalirudin‐associated intracoronary thrombosis during γ‐brachytherapy and its experimental validation in acute swine model

L. Satler, R. Waksman, S. Rha, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Identification of "vulnerable plaque" using virtual histology in angiographically benign looking lesion of proximal left anterior descending artery.

K. Kent, A. Pichard, L. Satler, 2003, Cardiovascular Radiation Medicine.